(RTTNews) - Aileron Therapeutics, Inc. (ALRN), Wednesday announced positive topline data from the cohort 2 of Phase 1b study evaluating LTI-03 in patients with idiopathic pulmonary fibrosis (IPF).

Survival rates for idiopathic pulmonary fibrosis are worse than all solid cancers except for lung and pancreatic cancer. | ...

Aileron Therapeutics' Phase 1b trial shows LTI-03 improved biomarkers and reduced SPD levels, indicating the potential to ...

TCGFB, a private biotech founded by healthcare VC The Column Group, is tapping California biotech Surrozen to discover ...

Insilico Medicine plans to push its computer-designed drug into pivotal clinical trials after a phase 2a study demonstrated ...

Lung transplantation remains a vital option for advanced IPF, with increasing transplant numbers and evolving allocation strategies. Idiopathic pulmonary fibrosis (IPF) is characterized by a ...

The term “progressive pulmonary fibrosis” or “PPF” is generally used to describe progressive lung fibrosis in an individual with an interstitial lung disease (ILD) other than idiopathic ...

Identifying the underlying causes of prolonged lung inflammation associated with radiographic abnormalities could be key understanding long COVID and other lung conditions, researchers say.

Miliary infections, being hematogenous, have a random distribution but tend to involve mainly the lower lung zones ... 2-19–2-23). Fibrosis can usually be recognized on HRCT by the presence ...

Johnnie Walker signed off his BBC Radio 2 show with an emotional message as he brought his 58-year career at the broadcaster to a close on Sunday, 27 October. The 79-year-old Sounds of the 70s ...

Frequent appointments and testing are part of life with idiopathic pulmonary fibrosis (IPF). I’ve been living with ... of pulmonary function tests (PFTs), which measure how well my lungs are working, ...